During the 1980s and 1990s, Malaysia had limited infrastructure for moving university research through regulatory approval, manufacturing and commercialisation.
Professor Aini worked closely with Remee Holdings, now known as Malaysian Vaccines and Pharmaceuticals Sdn Bhd, helping to train personnel, provide technical expertise and strengthen vaccine manufacturing capability. The partnership was instrumental in establishing the first and the only domestic animal vaccine company and reducing long-term reliance on imported vaccines. She also chaired work on Malaysia’s National Biotechnology Policy from 2001 to 2003 and contributed to national biotechnology institutions and research priorities.
At UPM, she continued this emphasis on translating knowledge into value. As Deputy Vice-Chancellor from 2008 to 2013, she helped strengthen the university’s research-to-market ecosystem. That foundation, Putra Science Park, has since supported thousands of intellectual properties, hundreds of commercialised technologies and close to 100 of start-ups.